ClinicalTrials.gg
RecruitingNCT05395247Updated Nov 12, 2026

Geriatric Assessment for Older Kidney Transplantation Candidates

An observational study in Chronic Kidney Diseases, sponsored by University Hospital, Caen. Recruiting at 1 site in France. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by University Hospital, Caen · Observational

How we know

From the registry’s dates

  • Started Jan 2019; still recruiting 7 years 10 months later.
Updated Nov 12, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 238 studies in Renal Insufficiency, Chronic with a site in France — 55 open to participants now, 69 under way, 17 of them phase 3. Renal Insufficiency, Chronic · France.

Planned enrollment
18th of 73
500 · median 165
Started
2019
with 12 others
Observational
73 of 238
20 open now
Primary completion
2027-12
later than 32 of 68 live
Registered
166th of 238
by date

Among the 238 studies in Renal Insufficiency, Chronic with a site in France, this one is the 18th largest by planned enrollment of the 73 observational ones that give a count, is one of 13 that started in 2019, is one of 73 observational ones, reaches primary completion later than 32 of the 68 other live ones, and was the 166th registered.

Renal Insufficiency, Chronic

3,098 studies on the registry are indexed under Renal Insufficiency, Chronic; 700 are open to participants now.

Browse Renal Insufficiency, Chronic studies →

Open to participants now

55 of the 238 studies in Renal Insufficiency, Chronic with a site in France are open now. Recruiting first, the newest first:

50 more — sign in →

All 55 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 434 Renal Insufficiency, Chronic studies recruiting now, 245 (56%) set no upper age limit and 110 (25%) stop at 75 or younger; 43 take children under 18; 80 take healthy volunteers.

This study: 65 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 238 studies in Renal Insufficiency, Chronic with a site in France, or all of them as a file.
02

Study summary

Geriatric assessment is now widely used to decide whether older patients with chronic kidney disease should be put on the kidney transplantation waiting list. This study aims to evaluate the association between Geriatric assessment and inscription on kidney transplantation.

Read the detailed description

There is a high proportion of older patients among patients with kidney failure, raising the question of the access to kidney transplantation within these patients. Geriatric assessment is now widely used to decide whether older patients with chronic kidney disease should be put on the kidney transplantation waiting list.

This study aims to evaluate the association between Geriatric assessment and inscription on kidney transplantation. Secondary objectives includes the analysis of the association between Geriatric assessment and:

  • post-kidney transplantation outcomes
  • quality of life.

It also includes the evolution of Geriatric assessment while still on waiting list and after kidney transplantation.

This study takes place in an University Hospital in Caen, France. This hospital is the only one performing kidney transplantation in the three French departments around. Candidates for kidney transplantation older than 70 years are systematically evaluated by a trained nurse and a geriatrician to perform a comprehensive geriatric assessment, evaluating cognitive functions, risk of fall, nutrition, frailty, functional status, and depressive symptoms. These patients are followed-up each year while still on the waiting list, and once after kidney transplantation. All patients evaluated within this consultation are proposed to enter the study. Patients are excluded in case of refusal or if they are unable to provide informed consent. The inclusion began in January 2019.

03

Conditions studied

  • Chronic Kidney Diseases

Keywords

  • chronic kidney disease
  • kidney transplantation
  • comprehensive geriatric assessment
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients with chronic kidney disease stages 4-5 treated or not by dialysis or kidney transplantation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients addressed for Geriatric assessment before inscription on kidney transplantation waiting list in Caen University Hospital, France

Exclusion criteria

Exclusion Criteria:

  • Patient refusal
  • Patient unable to provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Interventions

  • OtherGeriatric assessment

    Geriatric assessment by a trained nurse and a geriatrician for older kidney transplantation candidates in Caen University Hospital. The geriatric assessment includes a evaluation of cognitive functions, depressive symptoms, risk of fall, nutrition, frailty, and functional status.

06

What researchers measure

Primary outcomes

  1. Inscription on kidney transplantation waiting list

    Inscription on kidney transplantation waiting list

    Time frame: 6 months

Secondary outcomes

  1. Length of hospitalization in the year following kidney transplantation

    Units: days

    Time frame: 1 year after kidney transplantation

  2. Delayed renal recovery following kidney transplantation

    Dialysis requirement during the first week after kidney transplantation

    Time frame: 1 week after kidney transplantation

  3. Mortality

    Death in the year following kidney transplantation

    Time frame: 1 year after kidney transplantation

Other outcomes

  1. Evolution of quality of life while on waiting list and after kidney transplantation

    Assessed by the SF12 score before and in the year after kidney transplantation

    Time frame: 1 year after kidney transplantation

  2. Evolution of cognitive functions while on waiting list and after kidney transplantation

    Cognitive functions assessed by MMSE score

    Time frame: 1 year after kidney transplantation

  3. Evolution of executive functions while on waiting list and after kidney transplantation

    Executive functions assessed by BREF test

    Time frame: 1 year after kidney transplantation

  4. Evolution of mood while on waiting list and after kidney transplantation

    Mood assessed by the mini GDS scale

    Time frame: 1 year after kidney transplantation

  5. Evolution of frailty while on waiting list and after kidney transplantation

    Frailty assessed by the Rockwood scale

    Time frame: 1 year after kidney transplantation

  6. Evolution of functionnal status while on waiting list and after kidney transplantation

    Functionnal status assessed by activities of daily living scales

    Time frame: 1 year after kidney transplantation

  7. Evolution of functionnal status while on waiting list and after kidney transplantation

    Functionnal status assessed by the walk speed in m/s

    Time frame: 1 year after kidney transplantation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Data would be available on reasonable request

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2019 (actual). Primary completion is estimated for Dec 2027, 107 months after the start.

Of 276 non-industry observational studies under Renal Insufficiency, Chronic, half reached primary completion within 59 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 192. This study's planned 107 months is above that.

Counting every sponsor, half of 327 studies reached it within 45 months; a quarter within 22 and three quarters within 191.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: primary completion Dec 2024 → Dec 2027 and completion Jan 2025 → Jan 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 8, 2022
First posted
May 27, 2022
StartActual
Jan 1, 2019
Primary completionEst.
Dec 31, 2027was Dec 2024
CompletionEst.
Jan 1, 2028was Jan 2025
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Dec 31, 2024→Dec 31, 2027
Nov 12, 2026
Study completion
Jan 1, 2025→Jan 1, 2028
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Primary completion Dec 31, 2024→Dec 31, 2027
    Study completion Jan 1, 2025→Jan 1, 2028
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05395247
Responsible party
Sponsor
First posted
May 27, 2022
Start date
Jan 1, 2019
Primary completion
Dec 31, 2027 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Cédric Villain, MD, PhD
Contact
villain-c@chu-caen.fr
+33 2 31 06 30 51
Cédric Villain, MD, PhD
principal investigator · Department of Geriatrics, Caen University Hospital, Caen, France

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion